Compare SMTC & DVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SMTC | DVA |
|---|---|---|
| Founded | 1960 | 1994 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Misc Health and Biotechnology Services |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.0B | 10.0B |
| IPO Year | 2000 | 2002 |
| Metric | SMTC | DVA |
|---|---|---|
| Price | $106.57 | $154.57 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 15 | 4 |
| Target Price | $93.20 | ★ $156.75 |
| AVG Volume (30 Days) | ★ 2.4M | 579.3K |
| Earning Date | 05-26-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 79.65 | N/A |
| EPS | N/A | ★ 9.84 |
| Revenue | $1,049,975,000.00 | ★ $13,643,069,000.00 |
| Revenue This Year | $20.10 | $3.85 |
| Revenue Next Year | $13.01 | $3.07 |
| P/E Ratio | ★ N/A | $15.43 |
| Revenue Growth | ★ 15.47 | 6.46 |
| 52 Week Low | $28.91 | $101.00 |
| 52 Week High | $110.55 | $159.42 |
| Indicator | SMTC | DVA |
|---|---|---|
| Relative Strength Index (RSI) | 68.21 | 58.30 |
| Support Level | $62.94 | $144.98 |
| Resistance Level | N/A | $157.93 |
| Average True Range (ATR) | 5.51 | 3.42 |
| MACD | 2.13 | 0.18 |
| Stochastic Oscillator | 86.76 | 91.80 |
Semtech Corp is a provider of high-performance semiconductors powering data center networking, Internet of Things ("IoT") connectivity, and cellular infrastructure solutions. The company designs, develops, manufactures, and markets a diverse portfolio of products for commercial applications, addressing the infrastructure, high-end consumer, and industrial end markets. The company operates in four reportable segments: Signal Integrity, Analog Mixed Signal and Wireless, IoT Systems, and Connected Services. The majority of the company's revenue is earned through the Analog Mixed Signal and Wireless segment. Geographically, the majority of the company's revenue is earned from the Asia Pacific region; the company also operates in North America and Europe.
DaVita is the largest provider of dialysis services in the United States, boasting market share of about 35% when measured by clinics. The firm operates over 3,000 facilities worldwide, mostly in the US, and treats about 280,000 patients globally each year. Government payers dominate US dialysis reimbursement. DaVita receives about two thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business.